1. Home
  2. BWBBP vs YDESW Comparison

BWBBP vs YDESW Comparison

Compare BWBBP & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgewater Bancshares Inc.

BWBBP

Bridgewater Bancshares Inc.

N/A

Current Price

$19.41

Market Cap

0.0

Sector

Finance

ML Signal

N/A

YDESW

YD Bio Limited Warrants

N/A

Current Price

$0.90

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BWBBP
YDESW
Founded
N/A
N/A
Country
United States
United States
Employees
325
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BWBBP
YDESW
Price
$19.41
$0.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
BWBBP
YDESW
Relative Strength Index (RSI) 49.74 42.54
Support Level $19.40 $0.76
Resistance Level $19.49 $1.05
Average True Range (ATR) 0.10 0.03
MACD 0.03 -0.00
Stochastic Oscillator 76.32 48.82

Price Performance

Historical Comparison
BWBBP
YDESW

About BWBBP Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

About YDESW YD Bio Limited Warrants

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: